logowsbdaily | Tue, 25 Jan 2022 08:54:46 EST Where you find Tomorrow’s Hot Stocks Yesterday! 

NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.

Ocugen, Inc.
(OCGN)

Ocugen, Inc.
263 Great Valley Parkway
Suite 160
Malvern, PA 19355
United States
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fu... Read More

Summary & Charts

Price$ 4.06-0.07 (-1.7%)
Day's Range$ 4.02 - 4.23 
Previous Close$ 4.13
Market Cap$ 808.7M USD
Short Interest %N/A
FloatN/A
OutstandingN/A
ExchangeNasdaqCM
IndustryBiotechnology
SectorHealthcare
Volume7.71M
Avg. Volume (20 day)13.61M
Rel. Volume (20 day)0.57
Rel. Volume (3 month)0.24
RatingB+Neutral
DCFN/AStrong Buy
Debt/Equity8.59 %Neutral
ROE-65.27 %Sell
ROA-40.90 %Neutral
P/E-16.96 %Strong Sell
P/B7.54 %Strong Buy
DateOpenHighLowCloseChangeVolumeR. Vol. (20d)R. Vol. (3m)Mentions
Jan 07, 2022$ 4.06$ 4.23$ 4.02$ 4.06-0.077,710,2980.570.243
Jan 06, 2022$ 4.18$ 4.33$ 3.90$ 4.13-0.058,890,8290.620.271
Jan 05, 2022$ 4.38$ 4.45$ 4.16$ 4.18-0.2910,204,6330.710.31
Jan 04, 2022$ 4.64$ 4.67$ 4.35$ 4.47-0.259,803,8660.670.311
Jan 03, 2022$ 4.57$ 4.90$ 4.46$ 4.72+0.1710,817,3050.730.34
Dec 31, 2021$ 4.87$ 4.88$ 4.53$ 4.55-0.2811,271,6330.740.36
Dec 30, 2021$ 4.17$ 5.06$ 4.14$ 4.83+0.4523,795,3441.560.768
Dec 29, 2021$ 4.65$ 4.68$ 4.21$ 4.38-0.3415,179,8431.020.498
Dec 28, 2021$ 5.09$ 5.19$ 4.66$ 4.72-0.3913,535,1940.920.445
Dec 27, 2021$ 5.21$ 5.28$ 5.08$ 5.11-0.197,262,3900.490.245
Dec 23, 2021$ 5.12$ 5.37$ 5.03$ 5.30+0.168,995,3420.550.294
Dec 22, 2021$ 5.38$ 5.41$ 5.04$ 5.14-0.329,822,7980.600.322
Dec 21, 2021$ 5.22$ 5.53$ 5.13$ 5.46+0.2913,116,7080.800.421
Dec 20, 2021$ 5.78$ 5.78$ 5.04$ 5.17-0.0723,133,5431.410.736
Dec 17, 2021$ 4.95$ 5.25$ 4.88$ 5.24+0.2215,811,0650.970.5011
Dec 16, 2021$ 5.46$ 5.52$ 5.00$ 5.02-0.4012,173,4640.750.383
Dec 15, 2021$ 5.08$ 5.58$ 4.74$ 5.42+0.6125,921,0691.590.807
Dec 14, 2021$ 5.21$ 5.28$ 4.68$ 4.81-0.4921,985,0771.390.683
Dec 13, 2021$ 5.36$ 5.45$ 5.14$ 5.30-0.0510,461,0670.690.323
Dec 10, 2021$ 5.63$ 5.69$ 5.26$ 5.35-0.3012,360,9060.800.382

News

The latest news about Ocugen, Inc. (OCGN).

The Motley Fool | 2022-01-07 06:00:00
Ocugen faces a few major challenges.
GlobeNewsWire | 2022-01-06 18:03:00
MALVERN, Pa., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc . (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19, today announced that it will be participating in H.C. Wainwright's Bioconnect Conference taking place next week on January 10-13, 2022.
The Motley Fool | 2021-12-31 22:01:06
There has been very good news about the COVID vaccine; however, the jab still hasn't been approved where it counts for the biotech.
Zacks Investment Research | 2021-12-31 09:58:20
Ocugen (OCGN) gains on Bharat Biotech's positive results from a study in the pediatric population.
The Motley Fool | 2021-12-31 05:56:00
Even with COVID-19 cases rising, the prospects for these stocks remain uncertain.
The Motley Fool | 2021-12-30 19:09:33
There was some very good news about its partner's coronavirus vaccine.
PennyStocks | 2021-12-30 13:37:36
Check these penny stocks out for your watchlist right now The post These Penny Stocks Are Climbing Right Now, Here's Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Earnings

DateTimeEPS ExpectedEPS Reported%Revenue ExpectedRevenue Reported%
2021-11-09BMO-0.04-0.0525%------
2021-08-06BMO-0.03-0.13333.33%------
2021-05-07BMO0.5-0.04-108%78M----
2020-11-06BMO-0.02-0.07250%------
2020-08-14BMO-0.04-0.19375%9K43K375.03%
2020-05-11BMO-0.05-0.0739.99%------
2020-03-27BMO-0.144.133050%------
2019-11-12BMO------------

Top Discussions

These are the top discussions over the last 24-hours that mention the OCGN stock ticker symbol.


Unusual Option Activity

Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.

TypeStrikeExp DateDTEBidAskLastVolumeOpen InterestVol/OIIV
CALL$ 22.5001/20/2220$ 15.90$ 17.35$ 17.344012911.383.52%
Last Updated: Thu, 30 Dec 2021 22:29 EST

Failures to Deliver

Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.

Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.

Last Updated: Tue, 14 Dec 2021 12:00 EST


Support & Feedback

Got feedback or suggestions for more awesomeness? Or wanna keep up to date with changes?

@wsbdaily@wsbdailywsbdaily subredditwsbdaily

No obligation, if you'd like to support us with development and hosting costs then

Buy Me A Coffee

Disclaimer

WE ARE NOT AFFILIATED WITH REDDIT, THE LEADERSHIP OR MODERATOR TEAMS OF ANY OF THE SUBREDDITS WE CRAWL NOR WITH ANY OTHER WEBSITE, COMPANY OR DATA PROVIDER FROM WHICH WE PULL AND/OR AGGREGATE DATA FROM.

ALL CONTENT ON THIS SITE IS SOLEY FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY. THE SITE AND CONTENT, ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED. ANY CONTENT OR STATEMENT HEREIN SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, OR AS AN OFFER TO BUY, SELL, OR SOLICIT THE PURCHASE OR SALE OF ANY SECURITY OR FINANCIAL INSTRUMENT. DO YOUR OWN DUE DILIGENCE.

THE INFORMATION ON THIS SITE IS NOT UPDATED IN REAL-TIME, EACH DATASET SPECIFIES WHEN IT WAS “LAST UPDATED”. MOST INFORMATION IS CURRENTLY INDEPENDENTLY PERIODICALLY UPDATED EVERY 30 TO 150 MINUTES AND ONLY WHEN THE MARKETS ARE CLOSED. YOU BEAR ALL RISKS ASSOCIATED WITH THE USE OF THE SITE AND CONTENT, INCLUDING WITHOUT LIMITATION, ANY RELIANCE ON THE ACCURACY, COMPLETENESS OR USEFULNESS OF ANY CONTENT AVAILABLE ON THE SITE. YOUR USE OF THE INFORMATION CONTAINED HEREIN IS SOLELY AT YOUR OWN RISK. DO YOUR OWN DUE DILIGENCE.

There are high risks associated with investing in securities. Investing in stocks, options, bonds, ETFs, mutual funds, and money market funds involve risk of substantial loss. Loss of principal is possible. Some high risk investments may use leverage, which will greatly accentuate any losses. Foreign investing involves special risks, including a greater volatility and political, economic and currency risks and differences in accounting methods. Any past investment performance is not a guarantee or predictor of future investment performance. DO YOUR OWN DUE DILIGENCE.

The software providing the content on this site is currently in an alpha state. Although care is taken to publish accurate data inaccurate information is very, very possible. Use at your own risk. DO YOUR OWN DUE DILIGENCE.